TLDR Super-enhancers control CD25 expression in specific cell types, affecting immune function.
The study investigates the regulation and function of CD25 expression through super-enhancer elements in mice. It reveals that distinct super-enhancer regions control constitutive and inducible CD25 expression in a cell type-specific manner. Deleting the upstream super-enhancer region affects constitutive CD25 expression on DN2/DN3 thymocytes and regulatory T cells, leading to autoimmune alopecia. In contrast, deleting an intronic region reduces IL-2-induced CD25 expression on peripheral T and NK cells. The study highlights the role of the mediator-1 coactivator and chromatin interactions in these processes, offering insights into manipulating CD25 expression in specific cell types.
26 citations
,
May 2020 in “JCI Insight” Alopecia areata involves specific immune cells, offering potential treatment targets.
321 citations
,
March 2015 in “Nature” Super-enhancers controlled by pioneer factors like SOX9 are crucial for stem cell adaptability and identity.
701 citations
,
August 2014 in “Nature medicine” Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.
1 citations
,
August 2025 in “Journal of Human Immunity” Minoxidil helps restore thymus size in 22q11.2 deletion syndrome.
October 2023 in “bioRxiv (Cold Spring Harbor Laboratory)” Early regulatory T cells are crucial for normal skin pigmentation.
130 citations
,
November 2017 in “Frontiers in Immunology” The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.
1 citations
,
December 2022 in “Frontiers in Immunology” Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.
30 citations
,
February 2023 in “Journal of Investigative Dermatology” OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.